It wasn’t always this way. Leveraging AI in drug development is not only thanks to growing access to semiconductor chips, but also how technology has allowed for quick and now cheap ways of mapping ...

Advanced silk-based protein bio-material company AMSilk has secured €52m ($61m) financing to support its next phase of ...

Genetically engineered cell lines used in biomedical research have long been prone to misidentification and unauthorized use, ...

MIT Technology Review is thrilled to announce the release of an all-new class of 35 Innovators Under 35, whose unique stories ...

An Australian-made invention could soon make it possible to detect cancer through a simple blood test. The technology, ...

While biotech hubs like Boston, San Francisco, San Diego and Raleigh-Durham, North Carolina, are home to thousands of ...

AI as defined by the UK Intellectual Property Office (‘UK IPO’) and European Patent Office (‘EPO’) Applications of AI in biotechnology How biotechnology companies can leverage AI to drive innovation ...

Attendees will gain actionable insights on drafting and prosecuting applications that withstand scrutiny, avoid invalidation, and align with both USPTO expectations and global patent norms. Add to ...